Clinical Trial Update: Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety data for TissueGene-C in osteoarthritis were reported in a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• TissueGene-C (TG-C)

Snippet

Sponsor: Kolon Life Science | Conditions: Degenerative Arthritis | Phase 2 | Status: COMPLETED